Open AccessAbstract 2858: Immuno-PET with site-specific labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake in a subcutaneous HER2 positive xenograft mouse model of ovarian adenocarcinoma
Author(s) -
Lotte K. Kristensen,
Camilla L. Christensen,
Camilla Knudsen,
Mette Munk Jensen,
Brian Agnew,
Andreas Kjær,
Carsten H. Nielsen
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-2858
Subject(s) - biodistribution , trastuzumab , monoclonal antibody , chemistry , in vivo , ex vivo , chelation , cancer research , carboplatin , antibody , cancer , medicine , in vitro , biochemistry , cisplatin , chemotherapy , immunology , breast cancer , biology , microbiology and biotechnology , organic chemistry